Growth Metrics

Ocugen (OCGN) EBITDA Margin (2020 - 2025)

Ocugen's EBITDA Margin history spans 7 years, with the latest figure at 9172.54% for Q4 2025.

  • For Q4 2025, EBITDA Margin rose 1098602.0% year-over-year to 9172.54%; the TTM value through Dec 2025 reached 1537.12%, down 20479.0%, while the annual FY2025 figure was 1537.12%, 20479.0% down from the prior year.
  • EBITDA Margin reached 9172.54% in Q4 2025 per OCGN's latest filing, up from 1141.84% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 35385.0% in Q1 2021 to a low of 5127.25% in Q3 2022.
  • Average EBITDA Margin over 5 years is 661.89%, with a median of 1175.44% recorded in 2024.
  • Peak YoY movement for EBITDA Margin: tumbled -3918800bps in 2022, then skyrocketed 1098602bps in 2025.
  • A 5-year view of EBITDA Margin shows it stood at 35385.0% in 2021, then crashed by -107bps to 2548.12% in 2022, then skyrocketed by 69bps to 779.06% in 2023, then plummeted by -133bps to 1813.48% in 2024, then soared by 606bps to 9172.54% in 2025.
  • Per Business Quant, the three most recent readings for OCGN's EBITDA Margin are 9172.54% (Q4 2025), 1141.84% (Q3 2025), and 1075.53% (Q2 2025).